- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/42 - Nitro radicals
Patent holdings for IPC class C07D 207/42
Total number of patents in this class: 14
10-year publication summary
|
0
|
3
|
1
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4747 |
2 |
| Shin Nippon Biomedical Laboratories, Ltd. | 89 |
2 |
| East China University of Science and Technology | 553 |
1 |
| Heptares Therapeutics Limited | 73 |
1 |
| Korea Research Institute of Bioscience and Biotechnology | 1065 |
1 |
| National University Corporation Chiba University | 504 |
1 |
| New York University | 1844 |
1 |
| Oxford University Innovation Limited | 1668 |
1 |
| Synact Pharma ApS | 24 |
1 |
| Arianegroup SAS | 539 |
1 |
| Nodthera Limited | 43 |
1 |
| Synact Pharma ApS | 1 |
1 |
| Other owners | 0 |